SynsoryBio

SynsoryBio is pioneering the development of a new generation of protein therapeutics engineered with conditional "if-then" logic. These advanced drugs are designed to intelligently sense their location within the body and selectively activate only when they reach diseased tissue. This innovative technology platform holds the potential to significantly broaden the therapeutic window for highly potent drugs, minimizing off-target effects and maximizing efficacy. The applications of this platform are vast, spanning a wide range of diseases, including various forms of cancer and autoimmune disorders, offering a promising avenue for more targeted and effective treatments.